 |
||||||||||||||||||
As employees pay a greater share of the cost of drugs, some employers are worried that they will forego needed medications and increase the likelihood of major medical expenses. A few employers now waive or reduce co-payments for certain medical conditions such as asthma and diabetes to improve compliance with treatment and reduce financial barriers to access. According to a Mercer study, 11 percent of employers are considering similar moves within the next two years to try to head off major medical expenses arising from mismanagement of these diseases. Among employers with 20,000 or more employees, 21 percent also are considering waivers or reduced co-pays while 9 percent currently have these provisions in place. Effective clinical management must accompany any change in prescription drug-plan benefits. Source: Managing Benefits Plans - January 2006
| |
Guarding
Against the Negative Consequences of Changes in Drug-Plan
Coverage
